BNR
Burning Rock Biotech Limited
NASDAQ · Healthcare · Medical - Diagnostics & Research · CN
$11.03
+2.32%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.36x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.51x
- Price / sales
- 1.52x
- Price / cash flow
- -22.81x
Enterprise value
- Enterprise value
- $57.4M
- EV / sales
- 0.75x
- EV / EBITDA
- -16.68x
- EV / EBIT
- -6.59x
- Market cap
- $116.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026